• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / U.S. Equity

Navigating an Overvalued Market, Part 2

I am big believer in using bull call spreads when pessimistic about market direction.
By BRET JENSEN
Feb 22, 2013 | 06:00 PM EST
Stocks quotes in this article: SPY, BBY, HLF, AVP, RIG, NDAQ, ABX, NTAP, KSS, JCP, SHLD, CY

In yesterday's column, I outlined why I believed the market is overdue for a 5% to 8% pull back. I don't see a major correction as Federal Reserve policies are still extraordinary supportive.

However, the shocks to consumer spending (payroll tax holiday expiration and high gas prices) and earnings estimates that have come down for 2013 even as the market has rallied over the last year are two large concerns. I believe the market has not factored either in fully yet.

Yesterday, I went through how I bought cheap insurance on my long portfolio by buying slightly out of the money puts on the S&P (SPY) and moved a decent portion of my portfolio over the last several weeks to cash.

Today I will go over how I am using out-of-the-money bull call spreads to keep my portfolio from underperforming too much due the cash in my portfolio. This will keep me in a better position if I am wrong about an impending decline in the market.

In Monday's column, I will cover several stocks on my "shopping list" if we do get the predicted pull back in equities.

I am big believer in using bull call spreads when I am pessimistic about the current market direction. It's also a very beneficial strategy to use when volatility and option premiums are low like they are now. I utilize short term bull call spreads on stocks that have recently been beaten down unfairly, for special situations or when I think the stock will significantly beat during an upcoming earnings report.

I try to structure my call spreads to return 300% or better if I turn out to be right. This way it can be a profitable strategy if I am only right a third of the time. These plays have been very kind to me so far in 2013 as about half of my calls have turned out to be correct so far.

I have scored 200% to 500% returns so far this year on Best Buy (BBY), Herbalife (HLF), Avon Products (AVP), Transocean (RIG) and Nasdaq OMX Group (NDAQ) while whiffing completely on Barrick Gold (ABX), NetApp (NTAP) and a few others. I try to post these moves on the Columnist Conversation section of these pages and tweet them as well when my positions are executed.

I use long term bull call option spreads for stocks that have not participated in the market rally and where sentiment on the equity is currently negative. I want them to be cheap and I want to be able to envision some catalysts that could unlock value over the next year. Here are two plays I made this week during the downturn.

Kohl's (KSS): Other than J.C. Penny (JCP) and Sears Holdings (SHLD), this probably is the most unloved department store retailer in the markets. However, the shares are cheap at around 10x forward earnings and they pay a dividend near 3%. The company has had some scattered rumors of being a takeover candidate. I don't believe that is likely, but it is a possibility if M&A activity continues to be robust.

More importantly the stock was selling 15% higher just a few months ago and Kohl's is selling at the bottom of their five year valuation range based on P/E, P/S, P/CF, P/B. The shares could benefit from doing a better job with their merchandising in 2013, attract interest from an activist hedge fund manager(s), or consumer spending turns out stronger than I expect or by continuing to raise their dividend.

Strategy: With the stock trading around $46.50, I bought some Jan. 14 $55/$57.50 bull call spreads for 60 cents. If I am right, I make a better than 300% return and it is a lower risk play than owning the stock in this challenged retailer directly.

Cypress Semiconductor (CY): This chip maker has seen better days and was 80% higher a year ago. The stock yields 4.5% and sells at 5x operating cash flow. Revenue is expected to post a 10% gain in FY2014 after being flat for this fiscal year so it might be a second half of the year story. In addition, Needham just upgraded the shares to a buy, the company's CFO recently made an insider purchase and the stock has built a base at these levels over the last four or five months.

Strategy: The stock is trading at $10, I bought some Jan. 14 $13/$15 bull call spreads this week for 25 cents. If the stock recovers just over half its decline it had in 2012 over the next year I can book a 700% gain for a very small outlay.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication the author held was long KSS and CY.

TAGS: Investing | U.S. Equity

More from U.S. Equity

Market's 'Superficial' Highs Are Only Skin Dip

James "Rev Shark" DePorre
Apr 9, 2021 4:36 PM EDT

You can't call this market overbought when so much of it isn't participating.

Market Checkup: What the Latest Charts and Data Are Saying

Guy Ortmann
Apr 9, 2021 10:03 AM EDT

The S&P 500's valuation continues to be extended.

Ericsson Is Setting Up Well as It Pushes Further Into 5G

Timothy Collins
Apr 8, 2021 5:30 PM EDT

Keep this one on the ready for entry Friday for a swing trade.

Shark Bites: Taking Advantage of Weak Biotechnology Action

James "Rev Shark" DePorre
Apr 8, 2021 12:16 PM EDT

The stock is trading near its recent secondary pricing and has very attractive price targets from analysts.

Walking Alone, Low Volume, Watching the Russell 2000, Fed Minutes, Margin Buying

Stephen Guilfoyle
Apr 8, 2021 7:53 AM EDT

Looking at a painting by Renoir side by side. You see beauty. I check my watch. The same is true with economic policy.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 04:44 PM EDT PAUL PRICE

    Pretty Incredible + Hard to Believe

  • 11:18 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    The 5 Pillars of Exceptional Trading
  • 08:05 AM EDT BOB LANG

    Bitcoin vs. Gold: Which Should You Invest In Now?

    Read my article TheStreet here!
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login